【摘要】 目的观察拉米夫定联合胸腺肽α1治疗慢性乙型肝炎的疗效。方法拉米夫定联合胸腺肽α1治疗24周后检查HBV-M及肝功能,并与对照组比较。结果治疗组肝功能好转,与对照组比较差异有统计学意义(P<0.05);HBeAg、HBV-DNA转阴率治疗组与对照组比较差异有统计学意义(P<0.05)。结论拉米夫定联合胸腺肽α1治疗慢性乙型肝炎效果肯定。更多还原

【Abstract】 Objective To observe the therapy effect of Lamivudine combined with thymic peptide-α1 on hepatitis B.Methods After 24 week treatment by using Lamivudine combined with thymic peptide-α1,the HBV-M and liver functions were examined and compared between the treatment group and the control group.Results The liver functions of the treatment group turned better compared with the control group,with a significant difference between the two groups(P<0.05),and there was a significant difference in the negative rates of HBeAg and HBV-DNA between the two groups(P<0.05).Conclusion Combination of Lamivudine with thymic peptide-α1 is very effective in the treatment of hepatitis B.更多还原